"OMICS Group is among best open access publishers with expert reviewers and renowned scientists in its editorial board. Both editors and reviewers actively participate in the peer-review process and helps in completing the review process within 21 days. Apart from that OMICS Group organizes more than 80 International Scientific conferences.The biomedical applications of plasmonic nanoparticles (NPs) use their optical scattering properties for imaging and diagnostics and their photothermal properties for various types of therapies through the generation of heat, vapor bubbles and acoustic waves. The specificity and sensitivity of imaging and diagnostics as well as the selectivity and efficacy of the therapeutic methods depend upon the selectivity of NP delivery and activation within their targets, typically diseased cells or tissues. The initial application of various NPs was based on passive targeting, which did not allow the NPs to recognize their specific molecular targets and resulted in the low selectivity of NP-based methods and also in potentially toxic loads of NPs. The situation was improved by using active molecular targeting with cell-specific molecules (peptides, antibodies, aptamers) attached to NPs and coupling to cognate receptors at the membranes of specific target (diseased) cells.
Title:Rainbow Plasmonic Nanobubbles: Synergistic Activation of Gold Nanoparticle Clusters
Author:Dmitri O Lapotko
OMICS Group is among the leading open access publishers with around 700+ peer-reviewed journals,which has more than 50,000+ editorial board members in its Editorial Board and many expert reviewers for rigorous peer-review process and OMICS Group organizes more than 3000+ International Scientific Conferences across the globe."
Last date updated on June, 2014